CSMS 49717184PGAACE OPSinformational

Entry Processing delays with FDA

Published Oct 8, 2021

Summary

CBP notes that entries containing FDA data may experience delayed FDA review and response times, and advises trade not to resubmit updates while FDA and CBP work to resolve the issue.

Summary is machine-generated at the linking layer for discovery only. Refer to the source bulletin for authoritative guidance.

CSMS 49717184 · full bulletin